Nominations Invited for 2013 AACR Team Science Award
PHILADELPHIA — The American Association for Cancer Research announces a call for nominations for the Seventh Annual AACR Team Science Award.
The AACR Team Science Award recognizes an outstanding interdisciplinary research team for its innovative and meritorious scientific work that has advanced or will likely advance our fundamental knowledge of cancer, or a team that has applied existing knowledge to advance the detection, diagnosis, prevention or treatment of cancer.
The award will be presented during the opening ceremony of the AACR Annual Meeting 2013, which will be held April 6-10, 2013, in Washington, D.C.
Last year’s award was presented to The Institute of Cancer Research (ICR) and The Royal Marsden Hospital: Cancer Research U.K. Cancer Therapeutics Unit and Drug Development Unit, led by Paul Workman, Ph.D., D.Sc., F.Med.Sci., Harrap professor of pharmacology and therapeutics and deputy chief executive at the ICR, as well as head of the division of cancer therapeutics and director of the Cancer Research U.K. Cancer Therapeutics Unit. The team’s many research accomplishments include the development of abiraterone, which is used to treat castration-resistant prostate cancer by inhibiting the enzyme CYP17A1, an enzyme required for the body’s production of testosterone.
The Seventh Annual AACR Team Science Award is generously supported by a $50,000 honorarium from Eli Lilly and Company.
- Deadline for nominations: Thursday, Sept. 6, 2012
- For more information, contact Monique P. Eversley at email@example.com or visit www.aacr.org/ScientificAwards.
About the AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR’s membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of individual and team science grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.